Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 150 | 2022 |
Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma N Beig, S Singh, K Bera, P Prasanna, G Singh, J Chen, ... Neuro-oncology 23 (2), 251-263, 2021 | 32 | 2021 |
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts D Zhang, HM Harris, J Chen, J Judy, G James, A Kelly, J McIntosh, ... Blood 141 (13), 1584-1596, 2023 | 16 | 2023 |
CD49d expression identifies a biologically distinct subtype of chronic lymphocytic leukemia with inferior progression-free survival on BTK inhibitor therapy A Alsadhan, J Chen, EM Gaglione, C Underbayev, PL Tuma, X Tian, ... Clinical Cancer Research 29 (18), 3612-3621, 2023 | 10 | 2023 |
Humoral and cellular immunogenicity of COVID-19 vaccinations in patients with CLL C Sun, EM Gaglione, LT Vaughn, R Mu, C Underbayev, J Chen, C Pleyer, ... Blood 138, 3724, 2021 | 5 | 2021 |
Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a … S Iyer, M Ismail, B Tamrazi, R Salloum, P de Blank, A Margol, R Correa, ... Frontiers in Oncology 12, 915143, 2022 | 3 | 2022 |
" Lesion-habitat" radiomics to distinguish radiation necrosis from tumor recurrence on post-treatment MRI in metastatic brain tumors R Correa, Q Lei, J Chen, J Zeng, J Yu, P Tiwari Medical Imaging 2020: Computer-Aided Diagnosis 11314, 704-709, 2020 | 3 | 2020 |
CLL-140 booster and BTKi interruption improve response to SARS-CoV-2 vaccine in patients with CLL E Bryer, S Paul, J Chen, C Pleyer, A Wiestner, C Sun Clinical Lymphoma Myeloma and Leukemia 22, S270-S271, 2022 | 2 | 2022 |
Sex-specific niche signaling contributes to sexual dimorphism following stem cell transplantation JNP Smith, BA Cordova, B Richardson, KF Christo, J Campanelli, ... bioRxiv, 2022.06. 13.495897, 2022 | 1 | 2022 |
NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS R Verma, Y Rauf, I Yadav, V Statsevych, J Chen, W Evanoff, M Ahluwalia, ... Neuro-Oncology Advances 3 (Supplement_4), iv6-iv6, 2021 | 1 | 2021 |
Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL E Bryer, S Paul, J Chen, C Pleyer, A Wiestner, C Sun Clinical Lymphoma, Myeloma & Leukemia 22, S142, 2022 | | 2022 |
3072–SEX-SPECIFIC NICHE SIGNALING CONTRIBUTES TO SEXUAL DIMORPHISM FOLLOWING STEM CELL TRANSPLANTATION A Desai, J Smith, B Cordova, B Richardson, K Christo, J Campanelli, ... Experimental Hematology 111, S80-S81, 2022 | | 2022 |
RADIOMIC FEATURES FROM LESION HABITAT PREDICT RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: A FEASIBILITY STUDY R Verma, Y Rauf, I Yadav, V Statsevych, J Chen, W Evanoff, M Ahluwalia, ... NEURO-ONCOLOGY 23, 141-141, 2021 | | 2021 |